11 overdoses reported in Winchester in two weeks - WSMV News 4

11 overdoses reported in Winchester in two weeks

Posted: Updated:

Investigators say fake prescription pills have hit the streets as dealers prey on a drug abuse epidemic.

Police in Winchester said there have been 11 overdoses in the past two weeks. All the cases stem back to two drugs.

“You never know what you’re going to get,” Winchester Police Chief Dennis Young said. “It could kill you.”

Young said a 23-year-old man died after taking a pill that looks like Percocet, but it was made of something entirely different.

The police chief traced the fake pills to six recent overdoses.

“Taking one of these pills, it’s playing Russian Roulette,” Young said.

According to Young, the pill actually consists of Fentanyl, an opiate-based drug far cheaper than Percocet. He said all it takes to trick buyers is a fake stamp.

The pills reportedly go for $6 each.

Officers have also dealt with a synthetic marijuana with a mysterious chemical makeup.

“They take one puff and they literary black out,” Young said. “Literally, they just black out.”

Its street name is Fruity Pebbles. Young said the strain is linked to five overdoses.

Young said the victims have been between the ages of 16 and 25. Some parents said they’re now acting more vigilant than ever.

“I think parents are going to have to pull their children a little closer of who they are hanging out with, what they’re doing,” said Denise Rudder of Winchester.

A TBI spokesperson said they processed the evidence and are helping Winchester police follow up on their investigation.

According to Young, investigators have identified some possible suspects. He said there is also a chance the drugs are being manufactured in Tennessee.

Police are offering a $1,000 reward for information that could lead to an arrest.

Copyright 2015 WSMV (Meredith Corporation). All rights reserved.

Powered by Frankly
Powered by WorldNow CNN
All content © 2018, WSMV; Nashville, TN. (A Meredith Corporation Station) . All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.